Error loading player: No playable sources found

Therapeutic Effect of Regdanvimab (CT‑P59) in Patients with Mild to Moderate Symptoms of SARS CoV 2 Infection

Date
January 13, 2021

Speaker

Speaker Image for Michael Ison
Northwestern/Celltrion, Inc.